新ATA指南应用导致大量补行全甲状腺切除以行辅助放射性碘治疗
该回顾性分析纳入1-4厘米的ATA低危和低中危分化型甲状腺癌患者,评估按2015年ATA指南辅助放射性碘治疗指征及补行全甲状腺切除的必要性。结果显示25.6%患者辅助放射性碘治疗受推荐,术前适合腺叶切除者中19.5%需补行全甲状腺切除。
要点
- 约20%术前适合腺叶切除的低危分化型甲状腺癌患者因病理发现需补行全甲状腺切除。
- 辅助放射性碘治疗推荐率较历史队列减少2.5倍。
- 病理结果可能改变低危患者的手术决策。
核心结论
- 尽管放射性碘治疗指征收紧,约20%术前适合腺叶切除的低危分化型甲状腺癌患者因病理发现需补行全甲状腺切除以行辅助放射性碘治疗。
研究设计与样本
- 回顾性分析纳入1000例中394例(39.4%)ATA低危和低中危1-4厘米分化型甲状腺癌患者。
主要发现
- 101/394(25.6%)患者辅助放射性碘治疗受推荐,为历史队列的2.5分之一。
- 术前适合腺叶切除的149例患者中,29例(19.5%)需补行全甲状腺切除以行辅助放射性碘治疗。
临床怎么用
- 对术前评估适合腺叶切除的低危分化型甲状腺癌患者,应告知术后病理可能需补行全甲状腺切除以行辅助放射性碘治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The recently published 2015 American Thyroid Association guidelines recognize lobectomy as a viable alternative for low-risk cancers and advise more conservative use of radioactive iodine. Some factors indicating adjuvant treatment with radioactive iodine (and therefore completion total thyroidectomy), however, only can be found upon pathologic investigation. METHODS: We performed a retrospective analysis including patients with American Thyroid Association low- and low-to-intermediate risk well-differentiated thyroid cancer 1-4 cm. We evaluated how often radioactive iodine would be indicated and compared this with our historic rate. A subanalysis was performed to determine the rate of completion total thyroidectomy necessary, based on the indications for adjuvant radioactive iodine therapy. RESULTS: A total of 394/1,000 (39.4%) patients were included for final analysis. Adjuvant radioactive iodine would have been favored in 101/394 (25.6%) of patients, which is 2.5 times less than was given in our historic cohort. Completion total thyroidectomy to enable adjuvant radioactive iodine would have been recommended in 29/149 (19.5%) patients preoperatively eligible for lobectomy. CONCLUSION: Despite the tightened regulations for radioactive iodine, about 20% of patients with apparently "low-risk" well-differentiated thyroid cancer who are eligible for lobectomy may need completion total thyroidectomy because of pathologic findings for which radioactive iodine use is listed as considered or favored by the current guidelines.
引用
- Kluijfhout WP, Pasternak JD, Drake FT, et al. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery. 2016. PMID: 27855968. doi:10.1016/j.surg.2016.05.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。